Evidence map›Paper›PMID 18339531›Full record

ReviewCurrent opinion in cell biology2008

Wnt/beta-catenin signaling: new (and old) players and new insights.

He Huang, Xi He

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in cell biology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 216 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
216citing papers in PubMed, 1 pooled it
23.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

216 citing papers in PubMed, 1 synthesis or guideline pooled it, 417 citations in OpenAlex.

  1. Pooled it
  2. The Axin2 rs2240308 polymorphism and susceptibility to lung cancer in a Chinese population.Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2014
    Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Excess Wnt in neurological disease.The Biochemical journal · 2025
    Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Romosozumab in osteoporosis: yesterday, today and tomorrow.Journal of translational medicine · 2023
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article

156 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

He HuangThe F M Kirby Neurobiology Center, Children's Hospital Boston, Harvard Medical School, Boston, MA 02115, USA.
Xi He
Boston Children's Hospital · US

Funding

Wnt/beta-catenin signaling: phosphorylation regulation of Wnt receptor-Axin interR01GM074241 · NIGMS · CHILDREN'S HOSPITAL BOSTON · PI HE, XI · 2005 to 2013
$2.5M
NIGMS NIH HHS R01 GM074241
6 · The paper itself

Abstract

Wnt/beta-catenin signaling has central roles in embryogenesis and human diseases including cancer. A central scheme of the Wnt pathway is to stabilize the transcription coactivator beta-catenin by preventing its phosphorylation-dependent degradation. Significant progress has been made toward the understanding of this crucial regulatory pathway, including the protein complex that promotes beta-catenin phosphorylation-degradation, and the mechanism by which the extracellular Wnt ligand engages cell surface receptors to inhibit beta-catenin phosphorylation-degradation. Here we review some recent discoveries in these two areas, and highlight some crucial questions that remain to be resolved.

Indexed as

Signal TransductionAnimalsAxin Proteinbeta CateninHumansProtein Processing, Post-TranslationalRepressor ProteinsTumor Suppressor ProteinsWnt ProteinsAxin Proteinbeta CateninRepressor ProteinsTumor Suppressor ProteinsWnt Proteins

Identifiers

PMID18339531
PMCPMC2390924
OpenAlexW2049920899

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.